Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Go back to Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
(NASDAQ: CABA) Delayed: 3.35 +0.10 (3.08%)
Previous Close $3.25    52 Week High
Open $3.24    52 Week Low
Day High $3.35    P/E N/A 
Day Low $3.23    EPS
Volume 1,559,223       

(NASDAQ: CABA) Delayed: 3.35 +0.10 (3.08%)
Previous Close $3.25    52 Week High
Open $3.24    52 Week Low
Day High $3.35    P/E N/A 
Day Low $3.23    EPS
Volume 1,559,223